- Home
- IMNM vs CTO Comparison
IMNM vs CTO Comparison
Compare IMNM & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- CTO
- Stock Information
- Founded
- IMNM 2006
- CTO 1902
- Country
- IMNM United States
- CTO United States
- Employees
- IMNM N/A
- CTO N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- CTO Real Estate Investment Trusts
- Sector
- IMNM Health Care
- CTO Real Estate
- Exchange
- IMNM Nasdaq
- CTO Nasdaq
- Market Cap
- IMNM 747.7M
- CTO 615.7M
- IPO Year
- IMNM 2020
- CTO N/A
- Fundamental
- Price
- IMNM $12.01
- CTO $20.14
- Analyst Decision
- IMNM Strong Buy
- CTO Strong Buy
- Analyst Count
- IMNM 5
- CTO 4
- Target Price
- IMNM $28.60
- CTO $21.50
- AVG Volume (30 Days)
- IMNM 803.1K
- CTO 430.9K
- Earning Date
- IMNM 11-13-2024
- CTO 10-24-2024
- Dividend Yield
- IMNM N/A
- CTO 7.37%
- EPS Growth
- IMNM N/A
- CTO N/A
- EPS
- IMNM N/A
- CTO 0.61
- Revenue
- IMNM $10,129,000.00
- CTO $118,662,000.00
- Revenue This Year
- IMNM N/A
- CTO N/A
- Revenue Next Year
- IMNM N/A
- CTO $13.12
- P/E Ratio
- IMNM N/A
- CTO $33.93
- Revenue Growth
- IMNM N/A
- CTO 16.61
- 52 Week Low
- IMNM $7.76
- CTO $16.16
- 52 Week High
- IMNM $30.96
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- IMNM 43.70
- CTO 62.68
- Support Level
- IMNM $12.99
- CTO $19.91
- Resistance Level
- IMNM $15.13
- CTO $20.74
- Average True Range (ATR)
- IMNM 0.93
- CTO 0.31
- MACD
- IMNM -0.16
- CTO 0.00
- Stochastic Oscillator
- IMNM 3.79
- CTO 86.75
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.